SCHEMBL571650

SCHEMBL571650

CC(C)=CCc1c(O)cc(O)c2c1OCC(c1ccc(O)cc1O)C2=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.77
TYR P14679 2/20 0.61
PTPN1 P18031 5/20 0.58
ESR1 P03372 2/20 0.52
ESR2 Q92731 2/20 0.52
MAOA P21397 2/20 0.52
CACNA1G O43497 2/20 0.52
CACNA1H O95180 2/20 0.52
ABCG2 Q9UNQ0 2/20 0.52
AKR1B10 O60218 1/20 0.52
AKR1B1 P15121 1/20 0.52
PDE5A O76074 1/20 0.52
CYP19A1 P11511 1/20 0.52
IDO1 P14902 2/20 0.51
MAOB P27338 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
ACHE P22303 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL1999608 0.99 HSP90AA1 (0.76) HSP90AA1TYRPTPN1ESR1ESR2
SCHEMBL30266617 0.87 HSP90AA1 (1.00) HSP90AA1TYRPTPN1ESR1ESR2
SCHEMBL27013629 0.87 HSP90AA1 (1.00) HSP90AA1TYRPTPN1ESR1ESR2
SCHEMBL13360711 0.87 HSP90AA1 (0.70) HSP90AA1TYRPTPN1ESR1ESR2
SCHEMBL1546594 0.85 TYR (0.81) HSP90AA1TYRPTPN1CYP19A1IDO1
SCHEMBL30523853 0.84 PTPN1 (0.81) HSP90AA1TYRPTPN1ESR1CACNA1G
SCHEMBL1999610 0.80 HSP90AA1 (0.51) HSP90AA1TYRPTPN1ESR1ESR2
SCHEMBL29876414 0.79 HSP90AA1 (0.48) HSP90AA1TYRPTPN1ESR1ESR2
SCHEMBL12866209 0.79 PTPN1 (0.82) HSP90AA1TYRPTPN1IDO1CYP3A4
SCHEMBL29516022 0.79 PTPN1 (0.82) HSP90AA1TYRPTPN1IDO1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150072-A1 COMPOSITIONS AND METHODS FOR THE PRESERVATION OF PLANT MATTER SINCLAIR DAVID A (US) 2023-08-10 WO disclosed
US-10184138-B2 Bacteria engineered for conversion of ethylene to ethanol THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-01-22 US disclosed
CN-105143457-B Fermenting and producing hydrocarbon 环球生物能源公司 2018-10-30 CN disclosed
US-20170137846-A1 BACTERIA ENGINEERED FOR CONVERSION OF ETHYLENE TO N-BUTANOL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-05-18 US disclosed
US-20160138058-A1 METHOD FOR PRODUCING ORGANIC COMPOSITIONS FROM OXYHYDROGEN AND CO2 VIA ACETOACETYL-COA AS INTERMEDIATE PRODUCT EVONIK DEGUSSA GMBH (DE) 2016-05-19 US disclosed
WO-2015191611-A1 BACTERIA ENGINEERED FOR CONVERSION OF ETHYLENE TO N-BUTANOL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-12-17 WO disclosed
CN-104321434-A Methods for biosynthesizing 1,3butadiene INVISTA TECH SARL 2015-01-28 CN disclosed
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
WO-2013186358-A1 ASYMMETRIC HYDRATION OF 4-HYDROXYSTYRENE DERIVATIVES EMPLOYING DECARBOXYLASES ACIB GMBH (AT) 2013-12-19 WO disclosed
EP-1322771-A2 MODIFIED i TET /i -INDUCIBLE SYSTEM FOR REGULATION OF GENE EXPRESSION IN PLANTS BASF Plant Science GmbH (DE) 2003-07-02 EP disclosed
WO-2002101023-A9 A METHOD FOR ALTERING THE ISOFLAVONOID PROFILE IN THE PLANT PARTS OF AN ISOFLAVONOID-PRODUCING PLANT DU PONT (US) 2003-02-06 WO disclosed
WO-2002101023-A2 A METHOD FOR ALTERING THE ISOFLAVONOID PROFILE IN THE PLANT PARTS OF AN ISOFLAVONOID-PRODUCING PLANT E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-12-19 WO disclosed
WO-2002020811-A2 MODIFIED TET-INDUCIBLE SYSTEM FOR REGULATION OF GENE EXPRESSION IN PLANTS BASF PLANT SCIENCE GMBH (DE) 2002-03-14 WO disclosed
WO-2002016423-A2 PLANT POLYNUCLEOTIDES ENCODING NOVEL Na+/H+ ANTIPORTERS BASF PLANT SCIENCE GMBH (DE) 2002-02-28 WO disclosed
WO-2002016625-A2 PLANT POLYNUCLEOTIDES ENCODING PRENYL PROTEASES BASF PLANT SCIENCE GMBH (DE) 2002-02-28 WO disclosed
EP-1100517-A1 NUTRIENT AND THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF CANCER Kosbab, John V. (US) 2001-05-23 EP disclosed
WO-2000029595-A1 PAD4 COMPOSITIONS AND METHODS THEREFOR UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE (US) 2000-05-25 WO disclosed
WO-2000007607-A1 NUTRIENT AND THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF CANCER KOSBAB, JOHN, V. (US) 2000-02-17 WO disclosed
EP-0378921-A2 Enhancement of plant metabolite production by timed elicitation IDAHO RESEARCH FOUNDATION, INC. (US) 1990-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 HSP90AA1 604/4885TYR 141/4885PTPN1 3544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.